Carregant...
Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients. Rituximab is a monoclonal antibody against CD20 antigen that is expressed in mature and immature B cells. Early experience with rituximab su...
Guardat en:
| Publicat a: | Turk J Ophthalmol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Galenos Publishing
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5282540/ https://ncbi.nlm.nih.gov/pubmed/28182165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjo.26780 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|